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Abstract
Objectives Although ultrasound (US) is considered one of
the safest imaging modalities, concerns have been raised
regarding potential infection transmission risks through
US procedures. A survey was undertaken by the
European Society of Radiology (ESR) to establish infec-
tion prevention and control measures in US and to high-
light the importance of good medical practice.
Methods An online survey was sent to all 22,000 full ESR
members.
Results The response rate of completed surveys was
4.3 % (946 practitioners, 97 % of which were radiolo-
gists, mostly working in larger hospital settings). Among
respondents, 29 %, 11 % and 6 % did not disinfect the
US probe after every patient when performing standard
surface US, endo-cavity US and interventional proce-
dures, respectively. Eleven percent did not always use
probe covers for endo-cavity US; for interventional pro-
cedures, the proportion was 23 %. A minority used sterile
gel sachets in direct patient contact for endo-cavity scans
(30 %), and 77.5 % used sterile gel for interventional
procedures.
Conclusions The survey results highlight a wide range
of practices throughout Europe and the need to raise
awareness amongst practitioners regarding the impor-
tance of infection prevention and control measures.
The development of European recommendations
encompassing all US examinations, together with educa-
tion is a priority.
Main Messages
• Transmission of infection through ultrasound procedures is
possible.
• There is a wide range of ultrasound probe decontamination
practices in Europe.
• Not all practitioners use probe covers for endo-cavity or
interventional ultrasound.
• Not all practitioners use sterile gel for internal and invasive
procedures.
• Currently there are no European recommendations
encompassing all US examinations.
Keywords Ultrasound . Gels . Infection prevention and
control . Decontamination . Disinfection
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Introduction
Ultrasound (US) is generally considered one of the saf-
est diagnostic modalities available. Neither professionals
nor patients undergoing US imaging anticipate that US
will cause significant harm. However, in recent years,
several outbreaks of infection related to endoscopic pro-
cedures or trans-oesophageal US have been reported
[1–5], resulting in the introduction of more stringent
infection prevention measures [6, 7].
Concerns have been raised that transmission of infection
may also pose a risk to patients in conventional US, in partic-
ular endo-cavity (i.e., trans-vaginal or trans-rectal) US,
performing US near wounds/stomas, or interventional proce-
dures involving US. Furthermore, there is a potential risk of
transmitting infection through US gel, and the risk of micro-
scopic or macroscopic probe cover perforations necessitates
consideration.
It is very difficult to prove contamination and the subse-
quent transmission of pathogens through US examinations,
but it should not be assumed that the risk does not exist.
Surveys in the UK have already revealed that there is a wide
range of practices, with the authors calling for national guid-
ance [8, 9]. To our knowledge, only European guidelines re-
lating to interventional US have been published [10]; no
European guidance is yet available encompassing all US
settings.
We report the results of a survey undertaken by the
European Society of Radiology (ESR) to identify current
European US infection prevention and control practices in
place and to raise awareness of the importance of appropriate
decontamination protocols.
Materials and methods
An online survey (using the SurveyMonkey software) was
sent to all full ESR members in Europe (22,000) in
September 2015.
A total of 22 questions were posed, initially regarding the
country and city of work, the work setting (private centre
versus hospital), size of the establishment and number of year-
ly US procedures undertaken. Thereafter, known incidents
involving transmission of infection were queried, with free
text available for further clarification.
The final part of the survey gathered detailed data on the
US gel used, both in direct contact with the patient and inside
probe covers. Decontamination procedures were surveyed
over a wide range of US examinations: standard surface US,
when scanning patients with known transmissible infections,
endo-cavity (trans-vaginal and trans-rectal) US, and US used
in an interventional setting (US-guided biopsy, drainage or US
used in theatre). Free text sections were available throughout
the survey (see Appendix 1).
Results
Of the 22,000 questionnaires sent, a total of 1088 replies
(4.94 %) were received, of which 946 (4.3 %) were complete
and subsequently analysed. Responses were gathered from
most European countries, with the largest numbers originating
from Italy, the UK, Spain and France.
The majority of survey respondents worked exclusively in
a hospital setting (81 %); the remainder worked in private
centres or offices (15 %), and 4 % indicated mixed/other work
commitments. Most practitioners (67 %) worked in relatively
large institutions (100–1000 beds), with 16%working in very
large hospitals of over 1000 beds. Twelve percent had no
patient admission facilities. The majority (88 %) performed
over 3000 US examinations per year, with 42 % of the insti-
tutions carrying out over 10,000 annual scans.
Almost all surveys were completed by radiologists (97 %).
Eight responses in total were received from cardiologists,
gynaecologists/obstetricians and urologists. Twenty replies
stated mixed practice or work in other specialties such as
breast services, paediatrics or emergency medicine.
Known cases of infection transmission through ultrasound
Of the 946 respondents, 26 (2.7%) stated that they were aware
of cases of infection transmission through US procedures.
Details provided in the free text section mentioned insufficient
infection prevention measures several times. Presumed
transmitted organisms included methicillin-resistant
Staphylococcus aureus (MRSA), Staphylococcus, cytomega-
lovirus and human papillomavirus, as well as cutaneous fun-
gal infection and scabies. Infections were recorded after breast
biopsy/drainage, following joint aspiration/injection, follow-
ing trans-vaginal US and after trans-rectal biopsy (the latter of
which is well recognised given the presence of bowel flora). A
few cases described skin infections and complications when
assessing wounds as well as gastroenteritis/gastroenterocolitis.
Others mentioned MRSAwithout offering further details.
Reviewing this subgroup in comparison to overall results
did not reveal relevant differences in infection prevention
measures recorded.
Surface ultrasound on unbroken skin (i.e., presumed
relatively low-risk procedures)
Most practitioners used either refill US gel bottles (520,
55 %) or single-use bottles (405, 43 %). Only 2 % used
sterile sachets.
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Almost two thirds of respondents decontaminated the US
probe by wiping off the US gel first with subsequent disinfec-
tion of probes with foam or wipe after each patient (618,
65 %), whilst 276 (29 %) disinfected the probes only at the
end of the list. Only 4 % used a dedicated washer to thorough-
ly decontaminate probes in this setting (see Fig. 1). A few
responses detailed other protocols or gave insufficient
information.
In the free text section, some practitioners stated that they
wiped the probe with a dry towel but that no subsequent dis-
infection measures were undertaken. A multitude of different
wipes and foam brands were detailed, and two respondents
mentioned the use of ultraviolet light sterilisation, but this
question was not answered by 803 respondents.
Cases with known infections (surface ultrasound
on unbroken skin)
When the patient was known to have a transmissible infection
(infection control cases), 724 (77 %) wiped off the US gel and
then used disinfecting wipes/foam after the procedure, and
174 (18 %) cleaned the probe in a dedicated washer. Forty-
eight (5 %) detailed other procedures or gave insufficient
information.
In the free text section, 60 respondents stated that in these
cases, they would use probe covers as an additional preventa-
tive step, but not all disinfected the probe after removal of the
protective sheath.
Endo-cavity ultrasound procedures (trans-vaginal
or trans-rectal ultrasound)
Most practitioners stated that they used a probe cover for
endo-cavity US scans at all times (697, 89 %), whilst 85
(11 %) did not (see Fig. 2). Unfortunately, 164 respondents
did not answer this question, possibly because they did not
perform these procedures.
A minority (110 respondents, 14 %) used sterile gel inside
the probe cover; most used either refill bottles (355, 46 %) or
single-use bottles (304, 40 %). A total of 177 respondents
skipped this question. Nearly a third, 233 (30 %), stated that
they used sterile gel in direct patient contact for endo-cavity
procedures (233, 30 %). Refill bottles were used by 269
(35 %), 271 (35 %) used gel from single-use bottles (see
Fig. 3), and 173 skipped this question.
With regard to endo-cavity US probe decontamination pro-
cedures, the majority of respondents (69 %) chose Bwiping off
ultrasound gel and disinfection after each patient with
foam/wipe^. A more thorough B3-step cleaning process^ with
high-level disinfectant wipes or Bprobe cleaning in dedicated
washer^ was chosen by 69 and 70 (9 %) practitioners, respec-
tively. Just over one in ten (86, 11 %) cleaned the probe only
after the list was finished and not after each patient (see
Fig. 1). A few practitioners detailed other procedures, and
166 skipped this question.
Interventional procedures
Over two thirds of practitioners taking part in this survey
stated that they performed interventional procedures (70 %).
Of these 666 interventional practitioners, the majority used
probe covers at all times (513, 77 %), whilst almost one quar-
ter (153, 23 %) did not (see Fig. 2).
The US gel inside the probe cover used for interventional
procedures was typically from either a refill bottle (269,
40.4 %) or a single-use bottle (229, 24.4 %), whilst 168
(25.2 %) used sterile sachets. US gel used in direct contact
during interventional procedures was mostly from sterile sa-
chets (516, 77.5 %). The remainder stated they used gel from
refill bottles (70, 10.5 %) or single-use bottles (80, 12 %) as
show in Fig. 3.
US probe decontamination procedures were similar to
endo-cavity probe disinfection, with most practitioners wiping
off the gel with subsequent disinfection after each patient
(507, 76 %), whilst 47 (7 %) used a thorough three-step
high-level disinfectant wipe cleaning process, and 66 (10 %)
used a dedicated probe washer (see Fig. 1). A minority did not
disinfect the probe after each patient, but only after the list wasFig. 1 US probe decontamination
Fig. 2 Use of US probe covers at all times
Insights Imaging (2016) 7:841–847 843
finished (40, 6 %). Again, some practitioners detailed other
procedures which did not fit into the categories above or pro-
vided insufficient information. Several responses stated that
probe covers were used but that the probes were not
disinfected afterwards.
Discussion
Publications dating back to 1988 have raised concerns regard-
ing cross-infection risks of US procedures [11]. A case report
from the year 2000 describes the transmission of hepatitis C
during US-guided procedures in the setting of assisted con-
ception, the exact route of transmission being unclear [12].
Several other studies have highlighted that post-procedure
US probe contamination is significant, and that transmission
of infection is possible [8, 13–18]. Reviewing the literature
concerning US-guided procedures, an overall incidence of
infectious complications of 0.1 % has been reported [19].
This rate may increase to 0.19 % after trans-bronchial endo-
scopic US-guided needle aspiration [20] and to 4.29 % after
trans-rectal prostate biopsy [21].
Infections may be clinically silent and discovered only at a
later date, potentially not connected to previous US examina-
tions. Obtaining proof that an infection is due to previous US
investigations can be difficult unless incidents emerge with a
traceable originating source. Also, some incidents of infection
transmission will not have been published.
The survey reported here confirms a very wide range of
practices throughout Europe. Twenty-six practitioners stated
that they knew of cases of infection transmission through US
procedures, proving that this is a topic worth considering. The
actual figure of US probe contamination and transmission of
infection is unknown, and is potentially higher, as an estimat-
ed risk study from France shows [22], even though another
French study did not find an increased risk of acquired HIVor
hepatitis C infections following trans-vaginal US procedures
[23]. Whatever the anticipated risk, known avoidable
healthcare-acquired infections are likely to be reviewed with
increasing scrutiny. In addition, all US practitioners have an
ethical obligation to keep their patients as safe as possible, and
hence should seek to minimise risk wherever possible.
Potential risks can be minimised by reducing transducer
contamination, better US probe decontamination after every
patient and by the use of appropriate US gel:
1. Reduction of US probe contamination (use of probe
covers)
Basic hygiene protocols such as hand washing, the use
of gloves and keeping surfaces clean are essential first
infection prevention and control measures. In addition,
the use of transducer covers can lower contamination
levels, particularly in interventional or endo-cavity US
and whenever skin is not intact (i.e., when scanning close
to wounds or stomas).
The survey results show that a significant minority did
not always use probe covers for endo-cavity scans (11 %)
or interventional procedures (23%), possibly due to a lack
of awareness.
The use of sterile probe covers is strongly recommend-
ed in the recently published EFSUMB Guidelines on
Interventional Ultrasound, which also emphasise that
subsequent transducer decontamination after every pa-
tient is needed [10]. The latter is important, as varying
rates of probe cover perforations have been reported,
ranging from 2 % [24] to 9 % of cases [25], and even
up to 81 % in one older study [26]. Less frequent perfo-
rations were reported when condoms were used for trans-
vaginal US rather than US probe covers [27, 28], but
published studies are somewhat dated. Visual inspection
may significantly underestimate contamination levels and
is therefore unreliable [29]. Even when performing low-
level decontamination, e.g., single-step wiping of probes
with a disinfectant, persistent contamination was found
on trans-vaginal US probes after probe covers had been
used [8, 16].
2. Choice of US gel
Gels used for medical purposes do not have bacterio-
static properties per se, and cannot be viewed as sterile
unless specifically stated by the manufacturer. This was
proven by studies in the 1990s [30, 31]. Contaminated US
Fig. 3 US gel used
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gel has been identified in routine cultures, and several
reports of outbreaks of infection related to US gel have
been published [18, 32–35].
In this survey, a minority of practitioners used sterile
gel sachets in direct patient contact for endo-cavity scans
(30 %), whilst the majority used sterile gel for interven-
tional procedures (77.5 %). Again, it appears that increas-
ing awareness is important. It is also noted that a minority
used sterile gel inside transducer covers. Considering the
significant reported probe cover perforation rates (see
above), it is debatable whether the use of sterile gel would
lower infection rates.
Recommendations regarding the safe use of US gels,
including gel warmers, were published by Oleszkowicz
et al. in 2012 [36]. The newly published EFSUMB
Guidelines on Interventional Ultrasound recommend the
use of sterile gel in interventional US, and state that new
sachets should be opened for every patient [10]. We
would agree with this advice.
3. US probe decontamination
Complete decontamination of US transducers is chal-
lenging [8, 37]. A study testing the susceptibility of hu-
man papillomavirus, for example, showed that many dis-
infectants (including alcohol) may have limited to no ef-
fect [37], which is concerning and necessitates a general
review of decontamination protocols used.
Wiping probes with a dry towel resulted in persistent
contamination [18]. Many potent and proven in vitro-
effective chemical disinfectants, such as glutaraldehyde,
can pose health hazards to staff in direct skin contact or
through inhalation, as well as causing unhealthy work
environments for staff and patients. The nature of the
US probe surface must be considered as well, and its
susceptibility to damage by chemicals—for example, al-
cohol [38]. Individual manufacturers should provide de-
tailed information on which disinfectants are compatible,
and should be prepared to provide further product testing
upon request.
Questionnaire responses reveal that not all practitioners
disinfected the US transducers after every patient: 29 %,
11 % and 6 % of respondents did not disinfect the US
probe after every patient when performing standard sur-
face US, endo-cavity US and interventional procedures
respectively. It seems that more needs to be done to em-
phasise the importance of adequate US transducer decon-
tamination after every patient, and not just at the end of
the US list.
We acknowledge that implementing any additional in-
fection prevention measures will not be cost-neutral.
Capital investment for additional transducers and decon-
tamination equipment may be needed, and there will be
higher ongoing costs for probe covers and sterile gel. All
staff working in US departments must be adequately
trained in using the available resources as effectively as
possible.
Recommendations available to date include the
European guidelines on interventional US mentioned
above, which contain sections on infection prevention
[10]. The British Medical Ultrasound Society (BMUS)
published a survey and guidance in 2003 [9], but
whilst very valuable at the time, this advice was never
adopted UK-wide. NHS Health Scotland has just pub-
lished a document, Guidance for Decontamination of
Semi-Critical Ultrasound Probes; Semi-invasive and
Non-invasive Ultrasound Probes [39], regarding rec-
ommended protocols. Several more recent publications
from the USA and Canada relating to the safe use of
medical gel and US probe decontamination are avail-
able, as well as guidance from Australasia and France
[40–45]. Many local infection prevention and control
guidelines also exist. However, to our knowledge,
there are no specific published European or interna-
tional guidelines available to advise general US prac-
titioners on infection prevention and control matters.
Up-to-date European expert recommendations, after a
thorough literature review, would be helpful for
protecting patients and ensuring that US examinations
are as safe as possible.
Limitations
The limitations of this survey include the relatively low
response rate, with only 946 completed questionnaires
(4.3 %). This may partly reflect the fact that not all radiol-
ogists performing US examinations (in 2015, just under
half of the full ESR Radiologist Members chose US as
one of their special interests), or in some departments, only
the US lead radiologist may have completed the survey.
There was unequal representation among European coun-
tries, with a larger number of responses from Italy, the UK,
Spain and France. The vast majority of responses came
from hospital settings, and a smaller number were received
from private centres, which may not fully represent the
second group. This survey focussed on infection preven-
tion issues relating to US procedures. To keep the ques-
tionnaire as short as possible, the more wide-ranging basic
infection prevention and control precautions such as hand
washing, the use of gloves and protective drapes, and the
cleaning of US machines (apart from transducers) and oth-
er surfaces were not explored. No question was included
about the use of US gel warmers. Finally, we did not in-
clude options to allow for differences in the complexity of
interventional procedures.
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Conclusion
These survey results underscore the importance of raising
awareness amongst clinicians of the risks of infection asso-
ciated with US, in particular when transducers are in con-
tact with mucous membranes and potentially infected bodi-
ly fluids. Expert European recommendations are needed to
educate clinicians, guide best practices and ensure that safe
patient care is provided.
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